JY
CTSO icon

Jeff Yass’s Cytosorbents Corp CTSO Stock Holding History

Jeff Yass’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-29,945
Closed -$17K – 13550
2026
Q1 		$17K Sell
29,945
-53,418
-64% -$36.5K ﹤0.01% 12883
2025
Q4 		$53.3K Sell
83,363
-14,858
-15% -$11.4K ﹤0.01% 11730
2025
Q3 		$91.7K Sell
98,221
-33,632
-26% -$33.1K ﹤0.01% 11616
2025
Q2 		$169K Buy
+131,853
New +$132K ﹤0.01% 11379
2024
Q4 		– Sell
-11,033
Closed -$16.6K – 12338
2024
Q3 		$16.6K Sell
11,033
-78,755
-88% -$86.4K ﹤0.01% 11660
2024
Q2 		$63.1K Buy
89,788
+73,590
+454% +$63.8K ﹤0.01% 11308
2024
Q1 		$15.4K Buy
+16,198
New +$15.8K ﹤0.01% 11864
2023
Q3 		– Sell
-10,820
Closed -$38.8K – 12136
2023
Q2 		$38.8K Sell
10,820
-42,124
-80% -$133K ﹤0.01% 11435
2023
Q1 		$178K Buy
52,944
+21,001
+66% +$63K ﹤0.01% 10732
2022
Q4 		$49.5K Buy
31,943
+14,581
+84% +$21.6K ﹤0.01% 11405
2022
Q3 		$24K Sell
17,362
-33,900
-66% -$66.2K ﹤0.01% 12527
2022
Q2 		$112K Buy
+51,262
New +$118K ﹤0.01% 11362
2022
Q1 		– Sell
-23,988
Closed -$85.9K – 13115
2021
Q4 		$101K Buy
23,988
+3,213
+15% +$18K ﹤0.01% 12143
2021
Q3 		$169K Sell
20,775
-38,798
-65% -$315K ﹤0.01% 11674
2021
Q2 		$450K Sell
59,573
-15,664
-21% -$132K ﹤0.01% 9836
2021
Q1 		$653K Buy
75,237
+23,548
+46% +$224K ﹤0.01% 8843
2020
Q4 		$412K Sell
51,689
-22,155
-30% -$185K ﹤0.01% 8676
2020
Q3 		$589K Buy
73,844
+5,817
+9% +$52.5K ﹤0.01% 7331
2020
Q2 		$673K Sell
68,027
-58,528
-46% -$537K ﹤0.01% 6732
2020
Q1 		$978K Buy
126,555
+100,472
+385% +$507K ﹤0.01% 5459
2019
Q4 		$100K Sell
26,083
-18,511
-42% -$80.7K ﹤0.01% 9140
2019
Q3 		$224K Buy
44,594
+6,147
+16% +$35.8K ﹤0.01% 8877
2019
Q2 		$254K Buy
38,447
+27,860
+263% +$191K ﹤0.01% 8639
2019
Q1 		$80K Buy
+10,587
New +$82.4K ﹤0.01% 8329
2018
Q2 		– Sell
-115,419
Closed -$1.09M – 9685
2018
Q1 		$814K Buy
115,419
+53,510
+86% +$404K ﹤0.01% 5678
2017
Q4 		$402K Sell
61,909
-117,095
-65% -$745K ﹤0.01% 7045
2017
Q3 		$1.11M Buy
179,004
+105,170
+142% +$536K ﹤0.01% 5087
2017
Q2 		$317K Buy
73,834
+36,592
+98% +$160K ﹤0.01% 7486
2017
Q1 		$168K Buy
37,242
+25,895
+228% +$145K ﹤0.01% 8132
2016
Q4 		$62K Buy
+11,347
New +$62.1K ﹤0.01% 9235
2016
Q3 		– Sell
-22,848
Closed -$119K – 8467
2016
Q2 		$104K Sell
22,848
-14,949
-40% -$65.1K ﹤0.01% 8005
2016
Q1 		$148K Buy
37,797
+5,628
+17% +$24.4K ﹤0.01% 8218
2015
Q4 		$179K Sell
32,169
-14,331
-31% -$97.6K ﹤0.01% 8511
2015
Q3 		$293K Sell
46,500
-13,969
-23% -$93.2K ﹤0.01% 8072
2015
Q2 		$371K Buy
60,469
+16,531
+38% +$112K ﹤0.01% 8168
2015
Q1 		$580K Buy
+43,938
New +$452K ﹤0.01% 6821

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jeff Yass's CTSO Position: Q2 2026 in Review

Jeff Yass sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 29,945 shares — an estimated $17K sold.

Jeff Yass first reported a position in CTSO in Q1 2015 and held it in 36 quarters. The position peaked at $1.11M in Q3 2017. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Jeff Yass reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 29,945 Cytosorbents Corp shares in Q2 2026, an estimated $17K.
  • Jeff Yass first reported a position in Cytosorbents Corp in Q1 2015 and held it in 36 quarters.
  • Jeff Yass's Cytosorbents Corp position peaked at $1.11M in Q3 2017.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.